92 related articles for article (PubMed ID: 28823254)
1. [Expression of SHP-1 mRNA in Patients with Myelogenous Leukemia and Its Clinical Significance].
Liu XD; Liu X; Li YH; Zhang YX; Li ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):975-979. PubMed ID: 28823254
[TBL] [Abstract][Full Text] [Related]
2. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
[TBL] [Abstract][Full Text] [Related]
3. [Expression and Clinical Significance of DNMT in Patients with Chronic Myeloid Leukemia].
Li YH; Liu XD; Guo XF; Liu X; Luo JM; Zhang YX; Li ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1547-50. PubMed ID: 26708868
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
5. Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia.
Papadopoulou V; Kontandreopoulou E; Panayiotidis P; Roumelioti M; Angelopoulou M; Kyriazopoulou L; Diamantopoulos PT; Vaiopoulos G; Variami E; Kotsianidis I; Athina Viniou N
Leuk Lymphoma; 2016 May; 57(5):1182-8. PubMed ID: 26373709
[TBL] [Abstract][Full Text] [Related]
6. [Expression of eIF4E in patients with leukemia and its clinical significance].
Zhu LF; Chen XJ; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):1-6. PubMed ID: 23484680
[TBL] [Abstract][Full Text] [Related]
7. BCL11A expression in acute phase chronic myeloid leukemia.
Yin J; Zhang F; Tao H; Ma X; Su G; Xie X; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Wang Z; Chang W; Gale RP; Wu D; Yin B
Leuk Res; 2016 Aug; 47():88-92. PubMed ID: 27285855
[TBL] [Abstract][Full Text] [Related]
8. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
Xie XH; Chen ZZ; Zhang XM; Huang MQ
Ai Zheng; 2003 Jun; 22(6):616-9. PubMed ID: 12948412
[TBL] [Abstract][Full Text] [Related]
9. [The expression and clinical significance of hematopoietic cell phosphatase and cysteinyl aspartate-specific proteinase in leukemia].
Han Y; Luo JM; Jia XH; Wang FX; Yao L; Du XY
Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):363-5. PubMed ID: 16780734
[TBL] [Abstract][Full Text] [Related]
10. [Detection of SOCS-1 mRNA expression by RT-PCR in the patients with myeloid leukemia].
Yang HP; Dai M; Zhou HS; Huang L; Zhang DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):677-80. PubMed ID: 16928298
[TBL] [Abstract][Full Text] [Related]
11. [Treg Cells,
Wang SL; Dong QF; Li F; Wang J; Sang YQ; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):666-670. PubMed ID: 37356924
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
13. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
14. [Expression of c-fes gene in leukemia cells and its clinical significance].
Zhang YL; Ren JH; Guo XN; Zhang JN; Wang Y; Qiao SK; Lin FR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1429-33. PubMed ID: 20030920
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of helicase antigen in patients with acute and chronic myeloid leukemia.
Chen Q; Lin J; Qian J; Yao DM; Qian W; Li Y; Chai HY; Yang J; Wang CZ; Zhang M; Xiao GF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1171-5. PubMed ID: 22040965
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
Amadori S; Picardi A; Fazi P; Testi AM; Petti MC; Montefusco E; Mandelli F
Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
[TBL] [Abstract][Full Text] [Related]
17. The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.
Shen Q; Liu S; Hu J; Chen S; Yang L; Li B; Wu X; Ma Y; Yang J; Ma Y; Li Y
Cancer Cell Int; 2012 Oct; 12(1):42. PubMed ID: 23067006
[TBL] [Abstract][Full Text] [Related]
18. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
Motoji T
Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
20. [Comparative Analysis of Efficacy and Drug Resistance of Imatinib in Patients with Chronic Myeloid Leukemia at Chronic and Advanced Phases].
Wang W; Liu HB; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1039-43. PubMed ID: 27531771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
